Adult-Onset Type 1 Diabetes Increases Risk of Cardiovascular Disease
Drug Topics
MAY 14, 2025
Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.
Drug Topics
MAY 14, 2025
Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.
Pharmacy Times
MAY 14, 2025
The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 14, 2025
WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.
Pharmacy Times
MAY 14, 2025
Emrelis is a groundbreaking treatment for advanced non-small cell lung cancer, targeting high c-Met protein overexpression.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025
Pharmacy Times
MAY 14, 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 14, 2025
Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.
PharmExec
MAY 14, 2025
Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
Pharmacy Times
MAY 14, 2025
New trial results reveal icotrokinra's effectiveness in achieving significant skin clearance for challenging scalp and genital psoriasis.
Pharmaceutical Technology
MAY 14, 2025
The deal comes at a time of revival into liver disease treatment investment as market opportunity beckons.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 14, 2025
The seasonal surge in skin irritations underscores the ongoing need for effective and convenient remedies.
Fierce Healthcare
MAY 14, 2025
From Gen Z to Millennials to seniors, each age group has unique access challenges and care preferences when it comes to mental health treatment, the survey found.
Pharmacy Times
MAY 14, 2025
Effectively communicating research findings to patients, health care professionals, and policy payers is necessary for engagement.
Pharmaceutical Technology
MAY 14, 2025
Recipharm has joined forces with ProductLife Group (PLG) to support (bio)pharmaceutical firms in expediting market approval and trial time.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Fierce Healthcare
MAY 14, 2025
UnitedHealth Group revealed additional details about the compensation package for CEO Stephen Hemsley in a filing with the Securities and Exchange Commission.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The FDA Law Blog
MAY 14, 2025
By Mark A. Tobolowsky & Mark I. Schwartz In early April, Cellares became the first company to announce receipt of an Advanced Manufacturing Technology (AMT) designation from FDA. The designation was granted by CBER to Cellares for its automated cell therapy platform, the Cell Shuttle. We were excited to see the news and look forward to seeing the full implementation of the AMT program and its potential benefits.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
MAY 14, 2025
In todays digital-first healthcare landscape, programmatic display ads have become a cornerstone of pharmaceutical marketing strategies. By leveraging automated, data-driven ad placements, pharma brands can reach healthcare professionals (HCPs) and patients with unprecedented precision and efficiency. This guide delves into the essentials of programmatic advertising, its benefits, and best practices for pharma marketers.
pharmaphorum
MAY 14, 2025
Since December 2022, and COP decision 15/9, members of the Convention on Biological Diversity (the CBD) have been negotiating a multilateral mechanism for the fair and equitable sharing of benefits arising from the use of Digital Sequence Information (DSI) on genetic resources.
STAT
MAY 14, 2025
Drug deaths plummeted in 2024, according to new federal data. An estimated 80,391 people died of a drug overdose in the U.S. last year, marking the lowest total since 2019. The sum represents a roughly 27% decrease from 2023, according to the Centers for Disease Control and Prevention.
pharmaphorum
MAY 14, 2025
Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement
Drug Topics
MAY 14, 2025
Investigators also found that nocturnal hypoglycemia is a strong predictor of daytime hypoglycemia.
STAT
MAY 14, 2025
The World Health Organization, which faces an extraordinary financial crunch in the wake of the U.S. withdrawal from the agency, has dramatically trimmed its top management. Gone from the leadership is Mike Ryan , who has led the Health Emergencies Program since 2019 and who has been with the WHO, off and on, for decades. Recently Ryan has also been serving as the WHO’s executive director.
Drug Topics
MAY 14, 2025
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
STAT
MAY 14, 2025
SAN FRANCISCO — Former Food and Drug Administration Commissioner Robert Califf said health secretary Robert F. Kennedy Jr.’s hesitance to endorse vaccines is harming the American public. “Fundamental vaccination saves millions of lives every year already, and he’s busy eroding public confidence in it,” Califf said at STAT’s Breakthrough Summit West conference on Wednesday.
Drug Topics
MAY 14, 2025
Rick Sage, Executive Vice President of Innovation & Standards at NCPDP, discusses his role and how his team is using innovation to support the pharmacy profession.
PharmaVoice
MAY 14, 2025
While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, one biotech CEO said.
Drug Topics
MAY 14, 2025
In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists role in remote patient care amid a growing technological infrastructure.
STAT
MAY 14, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a lot going on today. A bunch of my colleagues are in San Francisco for our Breakthrough Summit West , which is focused on the impact of AI on health innovation. Among those taking the stage: Robert Califf and Reed Jobs.
Drug Topics
MAY 14, 2025
Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.
STAT
MAY 14, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning & happy Summit day!
Drug Topics
MAY 14, 2025
A panelist discusses how implementing point-of-care testing can help create a formal structure for pharmacists to be recognized as providers who can help reduce health care costs by offering accessible care options.
Let's personalize your content